Berberine reduces antipsychotic-associated weight gain in schizophrenia patients with low-level LDL: a pooled analysis of randomized controlled trial

Zongshi Qin

[P141] Berberine reduces antipsychotic-associated weight gain in schizophrenia patients with low-level LDL: a pooled analysis of randomized controlled trial

*Zongshi Qin^1,2, Jiani Wu³ (1. School of Public Health, Peking University, 2. Peking University Clinical Research Institute, 3. Guang'anmen Hospital, China Academy of Chinese Medical Sciences)

Keywords:Randomized controlled trial, Berberine, Schizophrenia, Metabolic syndrome, Weight gain

Abstract password authentication.
Password is required to view the abstract. Please enter a password to authenticate.

Presentation information

Schizophrenia 1 - Clinical (1)

[P141] Berberine reduces antipsychotic-associated weight gain in schizophrenia patients with low-level LDL: a pooled analysis of randomized controlled trial

Password